| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/02/2001 | WO2001055103A2 Chimeric neuropeptide y receptors |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 08/02/2001 | WO2001005808A3 In vitro selection and optional identification of polypeptides using solid support carriers |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | US20010011126 Isolated protein; genetic engineering |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398611A1 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | CA2398242A1 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306008A Conjugate of Lidamycin with active fragment of monoclonal antibody |
| 08/01/2001 | CN1069062C Use of follicle-stimulating hormone |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
| 07/31/2001 | US6267960 Administering monoclonal antibody designated atcc no. hb-12612, hb-12616, atcc no. hb12618, or atcc no. hb-12617 which binds specifically to extracellular domain of prostate stem cell antigen (psca) to inhibit growth of prostate tumor |
| 07/31/2001 | CA2276548C Improved methods for the preparation of endotoxin-binding proteins |
| 07/26/2001 | WO2001053486A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | WO2001053355A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053325A2 Method of affinity purifying proteins using modified bis-arsenical fluorescein |
| 07/26/2001 | WO2001052664A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | US20010009768 Polynucleotides encoding cytokine designated LERK-5 |
| 07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
| 07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1117805A2 Modified tgf-beta superfamily proteins |
| 07/25/2001 | EP1117804A2 Chimaeric proteins between members of tgf-beta superfamily |
| 07/25/2001 | EP1117795A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117693A2 Intein mediated peptide ligation |
| 07/25/2001 | EP1117679A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP0577605B1 G protein-coupled glutamate receptors |
| 07/25/2001 | CN1305531A Expression vector for use in one-step purification protocal |
| 07/25/2001 | CN1305526A Gene coding for heliomicine and use thereof |
| 07/25/2001 | CN1305525A Phagocytic assay method |
| 07/25/2001 | CN1305498A Peptide composition as immunogen for treatment of allergy |
| 07/25/2001 | CN1305387A Enhancement of antibody-cytokine fusion protein medicated immune responses by co-administration with prostaglandin inhibitor |
| 07/25/2001 | CN1305386A Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 07/25/2001 | CN1305003A Gene engineering process for preparing died/tried fusion protein of erythrocyte growth factor with improved bioactivity |
| 07/25/2001 | CN1068945C Safety human immunodeficiency virus antibody positiver serum substitute |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265544 Adipocyte-specific protein homologs |
| 07/24/2001 | US6265174 Methods and compositions for identifying and modulating ctionprotein-interactions |
| 07/24/2001 | CA2040810C Process for producing foreign proteins in streptomyces |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2001 | EP1115878A1 Recombinant celo virus and celo virus dna |
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115868A2 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115734A1 Method of measuring protein-protein interactions in living cells |
| 07/18/2001 | EP1115425A1 Autoantibody inhibitors |
| 07/18/2001 | EP0742830B1 Fusion proteins that include antibody and nonantibody portions |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304451A Fusion proteins of i(mycobacterium tuberuculosis) antigens and their uses |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6261787 Bifunctional molecules for delivery of therapeutics |
| 07/17/2001 | US6261550 Proteins with cores |
| 07/12/2001 | WO2001049870A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | WO2001049867A1 M cell directed vaccines |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049832A2 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049713A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | WO2001049318A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |